NW
REGN icon

NewEdge Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

NewEdge Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$452K Sell
585
-781
-57% -$598K 0.01% 844
2025
Q4 		$1.05M Buy
1,366
+845
+162% +$574K 0.01% 612
2025
Q3 		$336K Buy
+521
New +$295K ﹤0.01% 848
2025
Q2 		– Sell
-669
Closed -$425K – 1022
2025
Q1 		$425K Sell
669
-40,096
-98% -$27.6M 0.01% 693
2024
Q4 		$29M Buy
40,765
+3,636
+10% +$3.05M 0.5% 51
2024
Q3 		$39M Buy
37,129
+858
+2% +$955K 0.7% 34
2024
Q2 		$38.1M Buy
36,271
+11
+0% +$10.7K 0.83% 28
2024
Q1 		$34M Buy
36,260
+3,541
+11% +$3.37M 0.76% 29
2023
Q4 		$28.7M Buy
32,719
+4,287
+15% +$3.53M 0.73% 32
2023
Q3 		$23.4M Buy
28,432
+7,099
+33% +$5.58M 0.74% 33
2023
Q2 		$15.3M Buy
21,333
+737
+4% +$568K 0.51% 54
2023
Q1 		$16.9M Buy
20,596
+983
+5% +$741K 0.64% 43
2022
Q4 		$14.2M Buy
19,613
+875
+5% +$646K 0.61% 46
2022
Q3 		$12.9M Buy
18,738
+1,864
+11% +$1.17M 0.61% 48
2022
Q2 		$9.97M Buy
16,874
+571
+4% +$371K 0.45% 59
2022
Q1 		$11.4M Buy
16,303
+6,989
+75% +$4.42M 0.51% 48
2021
Q4 		$5.88M Buy
+9,314
New +$5.73M 0.25% 101
2021
Q2 		– Sell
-1,188
Closed -$562K – 306
2021
Q1 		$562K Buy
+1,188
New +$578K 0.06% 209

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

NewEdge Wealth's REGN Position: Q1 2026 in Review

NewEdge Wealth reduced its Regeneron Pharmaceuticals (REGN) stake by 57% in Q1 2026, selling an estimated $598K and leaving 585 shares worth $452K. The position accounts for 0.01% of the portfolio, ranked #844.

NewEdge Wealth first reported a position in REGN in Q1 2021 and has held it in 18 quarters since. The position peaked at $39M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • NewEdge Wealth held 585 shares of Regeneron Pharmaceuticals worth $452K as of Q1 2026.
  • NewEdge Wealth sold 781 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $598K.
  • Regeneron Pharmaceuticals made up 0.01% of NewEdge Wealth's portfolio in Q1 2026, its #844 holding.
  • NewEdge Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
  • NewEdge Wealth's Regeneron Pharmaceuticals position peaked at $39M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.